Mas825 (Anti-IL-18 & IL-1β)
Product Specifications
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Mas825 is a bispecific antibody targeting both IL-1β and IL-18, effectively modulating the inflammasome cascade in inflammatory diseases. It shows potential for treating patients with COVID-19 and systemic juvenile idiopathic arthritis (sJIA) complicated by macrophage activation syndrome (MAS) and interstitial lung disease (ILD) by reducing pro-inflammatory cytokines and neutrophil counts, thereby improving clinical outcomes. MW: 144.15 kDa.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681991-500 1x 500 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1991), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881815-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1815R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471531-100 1x 100 µL
IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/1531), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471187-100 1x 100 µL
PAX7 (PAX7/1187), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 